Asana Biosciences To Present Pre-Clinical Data For A Novel Dual Inhibitor Of B-Raf And PI3 Kinase Pathway At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC today announced that it will present preclinical data regarding its product candidate ASN003 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics meeting, being held in Boston, Massachusetts, from November 5 - 9, 2015. The presentation details are as follows:

Help employers find you! Check out all the jobs and post your resume.